Novel approaches to the prevention of head and neck cancer

Proceedings of the Society for Experimental Biology and Medicine

Volumn 216, Issue 2, 1997, Pages 275-282

  Schantz, Stimson P ^a   Ostroff, Jamie S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR MODIFICATION; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; DNA DAMAGE; HEAD AND NECK CANCER; HEALTH BEHAVIOR; LIFESTYLE; REVIEW; RISK ASSESSMENT; SMOKING CESSATION; TREATMENT PLANNING;

EID: 0030847427     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-216-44178     Document Type: Review

References (80)

1. Schantz SP, Harrison L, Hong WK. Tumors of the nasal cavity and paranasal sinuses, nasopharnx, oral cavity, and oropharynx. In: De Vita VT, Hellman S, Rosenberg SA, Eds. Cancer: Principles and Practices of Oncology. Philadelphia: J. B. Lippincott, pp 574-673, 1993.
2. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin Oncol 21:281-288, 1994.
3. Rothman KJ, Cann CI, Flanders D, Fried MP. Epidemiology of laryngeal cancer. Epidemiol Rev 2:195-209, 1980.
4. Schottenfeld D. The etiology and prevention of aerodigestive tract cancers. Adv Exp Med Biol 320:1-21, 1992.
5. SEER Cancer Statistics Review, 1973-1992. Bethesda, MD: U.S. Department of Health and Human Services, NIH Publication No. 96-2789, 1996.
6. Chen J, Katz RV, Krutchkoff DJ. Intraoral squamous cell carcinoma: Epidemiologic patterns in Connecticut from 1935 to 1985. Cancer 66:1288-1296, 1990.
7. Shemen LJ, Klotz J, Schottenfeld D, Strong E. Increase of tongue cancer in young men. JAMA 252:1857, 1984.
8. Schantz SP, Byers RM, Goepfert H. Tobacco and cancer of the tongue in young adults. JAMA 259:1943-1944, 1988.
9. Franchesci S, Levi F, Lucchini F, Negri E, Boyle P, LaVecchia C. Trends in cancer mortality in young adults in Europe, 1955-1989. Eur J Cancer 30A:2096-2118, 1994.
10. Wynder EL, Stellman SD. Comparative epidemiology of tobacco-related cancers. Cancer Res 37:4608-4622, 1977.
11. Wynder EL, Bross IJ, Feldman RM. A study of the etiological factors in cancer of the mouth. Cancer 6:1300-1322, 1957.
12. Franco EL, Kowalski LP, Oliviera BV, Curado MP, Pereira RN, Silva ME, Fava AS, Torloni H, Risk factors for oral cancer in Brazil: A case-control study. Int J Cancer 43:992-1000, 1989.
13. DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate. Mutat Res 114:59-83, 1983.
14. Hecht SS, Hoffmann D. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 8:273-294, 1989.
15. Wynder EL, Covey LS, Mabuchi K, Mushinski M. Environmental factors in cancer of the larynx: A second look. Cancer 38:1591-1601, 1976.
16. Gupta PC, Bhonsle RB, Mehta FS, Pindborg JJ. Mortality experience in relation to tobacco smoking and chewing habits from a 10-year follow-up study in Ernakulam district, Kerala. Int J Epidemiol 13:184-187, 1984.
17. Day GL, Blot WJ, Austin DF, Bernstein L, Greenberg RS, Preston-Martin S, Schoenberg JB, Winn DM, McLaughlin JK, Fraumeni JF Jr. Racial differences in risk of oral and pharyngeal cancer: Alcohol, tobacco, and other determinants. J Natl Cancer Inst 85:465-473, 1993.
18. Williams RR, Horn JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients. Interview study from the Third National Cancer Survey. J Natl Cancer Inst 5:301-306, 1977.
19. Polednak AP. Racial and Ethnic Differences in Disease. New York: Oxford University Press, 1989.
20. Greenberg RS, Haber MJ, Clark WS, Brockman JE, Liff JM, Schoenberg JB, Austin DF, Preston-Martin S, Sternhagen A, Winn DM. The relation of socioeconomic status to oral and pharyngeal cancer. Epidemiology 2:194-200, 1991.
21. Ernster VL, Selvin S, Sacks ST, Merrill DW, Holly EA. Major histologic types of cancers of the gum and mouth, esophagus, larynx, and lung by sex and income level. J Natl Cancer Inst 69:773-776, 1982.
22. Elwood JM, Pearson JCG, Skipper DH, Jackson SM. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx, and larynx. Int J Cancer 34:603-612, 1984.
23. Nebert DW. Role of genetics and drug metabolism in human cancer risk. Mutat Res 247:267-281, 1991.
24. Harris CC. Interindividual variation among humans in carcinogen metabolism, DNA adduct formation, and DNA repair. Carcinogenesis 10:1563-1566, 1989.
25. Shields PG, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA 266:681-687, 1991.
26. Hsu TC, Spitz MR, Schantz SP. Mutagen sensitivity: A biologic marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1:83-89, 1991.
27. Trizna Z, Schantz SP. Hereditary and environmental factors associated with risk and progression of head and neck cancer. Otolaryngol Clin North Am 25:1089-1103, 1992.
28. Schantz SP, Hsu TC. Mutagen-induce chromosome fragility within peripheral blood lymphocytes of head and neck cancer patients. Head Neck 11:337-342, 1989.
29. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR, Schantz SP. Chromosome sensitivity to bleomycin-induced mutagenesis in patients with upper aerodigestive cancers: A case-control analysis. Cancer Res 49:4626-4638, 1989.
30. Schantz SP, Hsu TC, Ainslie N, Moser RP. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosomal damage. JAMA 262:3313-3315, 1989.
31. Cloos J, Braakhuis BJ, Steen I, Copper MP, de Vries N, Nauta JJ, Snow GB. Increased mutagen sensitivity in head and neck squamous cell carcinoma patients, particularly those with multiple primary tumors. Int J Cancer 56:816-819, 1994.
32. Li AT, Wang TD, Yang RT. Pingyangomycin-induced chromosome damage in lymphocytes of laryngeal cancer patients and healthy control subjects. Head Neck 16:510, 1994.
33. U.S. Department of Health. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. Bethesda, MD: U.S. Public Health Service, PHS Report No. 1103, 1964.
34. U.S. Public Health Services. The Health Consequences of Smoking: A Report of the Surgeon General. Bethesda, MD: Department of Health and Human Services, DHHS Publication No. (CDC) 90-8416, 1990.
35. American Cancer Society. Cancer Facts & Figures-1996, Atlanta, GA: American Cancer Society, 1996.
36. Centers for Disease Control. Cigarette smoking among adults - United States, 1994. MMWR 45:588-590, 1996.
37. Lichtenstein E, Glasgow R. Smoking cessation: What have we learned over the past decade? J Consult Clin Psychol 60:518-527, 1992.
38. Orleans CT, Slade J, Eds. Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993.
39. Shiffman S. Smoking cessation treatment: Any progress? J Consult Clin Psychol 61:718-722, 1993.
40. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol 51:390-395, 1983.
41. Velicer WF, Prochaska JO, Rossi JS, Snow MG. Assessing outcome in smoking cessation studies. Psych Bull 111:23-41, 1992.
42. Centers for Disease Control and Prevention. Cigarette smoking among youth: United States, 1989. MMWR 40:712-715, 1991.
43. Pierce JP, Choi WS, Gilpin EA, Farkas AJ, Merritt RK. Validation of susceptibility as a predictor of which adolescents take up smoking in the United States. Health Psychol 15:355-361, 1996.
44. Berman BA, Gritz ER. Women and smoking: Current trends and issues for the 1990's. J Subst Abuse 3:221-238, 1991.
45. Fiore MC, Newcombe P, McBride P. Natural history and epidemiology of tobacco use and addiction. In: Orleans CT, Slade J, Eds. Nicotine Addiction: Principles and Management. New York: Oxford University Press, 1993.
46. U.S. Department of Health and Human Services. Smoking Cessation Practice Guidelines: Information for Specialists. Bethesda, MD: Department of Health and Human Services. AHCPR No. 96-0694, 1996.
47. Royce JM, Hymowitx N, Corbett K, Hartwell TD, Orlandi MA. Smoking cessation factors among African Americans and whites. Am J Public Health 83:220-226, 1993.
48. Lerman C, Orleans CT, Engstrom PF. Biological markers in smoking cessation treatment. Semin Oncol 20:359-367, 1993.
49. Gritz ER, Moon TE. The new cancer prevention and control. Cancer Epidemiol Biomarkers Prev 1:163-165, 1992.
50. Glynn TJ. Relative effectiveness of physician-initiated smoking cessation programs. Cancer Bull 40:359-364, 1988.
51. Ockene JK, Kristeller JL, Goldberg R, Ockene I, Merriam P, Barrett S, Pekow P, Hosmer D, Gianelly R. Smoking cessation and severity of disease: The coronary artery smoking intervention study. Health Psychol 11:119-126, 1992.
52. Pederson LL. Compliance with physician advice to quit smoking: A review of the literature. Prev Med 11:71-84, 1982.
53. Strecher VJ, Becker MH, Kirscht JP, Erater SA, Graham-Tomasi SA. Psychological aspects of changes in cigarette smoking behavior. Patient Educ & Counseling 7:249-262, 1985.
54. Stevens VJ, Glasgow RE, Hollis JF, Lichtenstein E, Vogt TM. A smoking cessation intervention for hospital patients. Med Care 31:65-72, 1993.
55. Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LC, Wong W, Belin TR, Calcaterra T, Robbins KT, Chonkich G, Beumer J, Ward PH. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2:261-270, 1993.
56. Ockene JK. Physician-delivered interventions for smoking cessation: Strategies for increasing effectiveness. Prev Med 16:723-737, 1987.
57. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 328:184-194, 1993.
58. Bowman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, Skingly P, Levine MN. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328:159-164, 1993.
59. Eriksen M, Kondo A. Smoking cessation for cancer patients: Rationale and approaches. Health Educ Res 4:489-494, 1989.
60. Hiyama T, Sato T, Yoshino K, Tsukuma H, Hanai A, Fujimoto I. Second primary cancer following laryngeal cancer with special reference to smoking habits. Jpn J Cancer Res 83:334-339, 1992.
61. Day GL, Blot WJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, Liff JM, Preston-Martin S, Sarkar S, Schoenberg JB, Fraumeni JF. Second cancers following oral and pharyngeal cancers: Role of tobacco and alcohol. J Natl Cancer Inst 86:131-137, 1994.
62. Johnston WD, Ballantyne AJ. Prognostic effect of tobacco and alcohol use in patients with oral tongue cancer. Am J Surg 134:444-447, 1977.
63. Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, Kraus DH, Schantz SP. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 75:569-576, 1995.
64. Orleans CT. Treating nicotine dependence in medical settings: A stepped care model. In: Orleans CT, Slade J, Eds. Nicotine Addiction: Principles and Management. New York: Oxford University Press, pp 145-161, 1993.
65. Schilling A, Conaway M, Wingate P, Atkins J, Berkowitz I, Clamon G, DiFino S, Vinciguerra V. Recruiting cancer patients to participate in motivating their relatives to quit smoking. Cancer 79:152-160, 1997.
66. Smart CR. Screening for cancer of the aerodigestive tract. Cancer 72(Suppl):1061-1065, 1993.
67. Prout MN, Morris SJ, Witzburg RA, Hurley C, Chatterjee S. A multidisciplinary educational program to promote head and neck cancer screening. J Cancer Educ 7:139-146, 1992.
68. Screening for Oral Cancer? Report of the U.S. Preventive Services Task Force. Baltimore, MD: Williams and Wilkins, pp 91-95, 1989.
69. Jullien JA, Zakrsewska JM, Downer MC, Speight PM. Attendance and compliance at an oral cancer screening programme in general medical practice. Eur J Cancer Part B, Oral Oncol 31B:202-206, 1995.
70. Frenandez GL, Sankaranarayanan R, Lence Anta JJ, Rodriguez Salva A, Maxwell Parkin D. An evaluation of the oral cancer control program in Cuba. Epidemiology 6:428-431, 1995.
71. Ikeda N, Downer MC, Ozowa Y, Inoue C, Mizuno T, Kawai T. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan. Community Dent Health 12:133-137, 1995.
72. Cowan CG, Gregg TA, Kee F. Prevention and detection of oral cancer: The views of primary care dentists in Northern Ireland. Br Dent J 179:338-342, 1995.
73. Speight PM, Elliott AE, Jullien JA, Downer MC, Zakzrewska JM. The use of artificial intelligence to identify people at risk of oral cancer and precancer. Br Dent J 179:382-387, 1995.
74. McGuire M, Lydiatt W, Trambert R, Shaha A, Schantz S. Head and neck screening day for the community. Ann N Y Acad Sci 768:286-288, 1995.
75. Sugarman PB, Savage NW. Exfoliative cytology in clinical oral pathology. Aust Dent J 41:71-74, 1996.
76. Bongers V, Snow GB, de Vries N, Cattan AR, Hall AG, van der Waal I, Braakhuis BJ. Second primary head and neck squamous cell carcinoma predicted by the glutathione S-transferase expression in health tissue in the direct vicinity of the first tumor. Lab Invest 73:503-510, 1995.
77. Sugerman PB, Savage NW. Exfoliative cytology in clinical oral pathology. Aust Dent J 41:71-74, 1996.
78. Kurokawa H, Tsuru S, Okada M, Nakamura T, Kajiyama M. Evaluation of tumor markers in patients with squamous cell carcinoma in the oral cavity. Int J Oral Maxillofac Surg 22:35-38, 1993.
79. Schantz SP, Alfano RR. Tissue autofluorescence as an intermediate endpoint in cancer chemoprevention trials. J Cell Biochem 17F:199-204, Suppl 1993.
80. Kolli V, Savage HE, Yao TJ, Schantz SP. Native cellular fluorescence of neoplastic upper aerodigestive mucosa. Arch Otolaryngol Head Neck Surg 121:1287-1292, 1995.